Back

Lower left ventricular ejection fraction can independently predict the poor response to immunosuppressive treatment in patients with cardiac sarcoidosis

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2018

About the speaker

Photo
Assistant Professor Kisho Ohtani

Kyushu University Graduate School of Medical Sciences, Fukuoka (Japan)

30 More presentations in this session

Presentation thumbnail
Doctor Y. Chia (Singapore, SG)
Abstract Slides
Presentation thumbnail
Mr V. Martinez Mateo (Alcazar de San Juan, ES)
Abstract Slides
Presentation thumbnail
Professor A. Grupper (Beer Yakov, IL)
Abstract Slides
Presentation thumbnail
Doctor O. Manintveld (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Doctor E. Cabrera Romero (Murcia, ES)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Impact of left ventricular ejection fraction on outcomes of cardiac resynchronisation therapy in cardiac sarcoidosis
22 May 2023
thumbnail
Webinar
Cardiac sarcoidosis: the multimodality imaging approach
25 April 2023
thumbnail
Congress Session
Rare causes of heart failure
18 May 2025
thumbnail
Congress Presentation
Effects of immunosuppressive therapy on the clinical outcomes in patients with cardiac sarcoidosis
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources